The goals of a Phase 2 clinical trial are to:
Usually less than a few hundred patients with the same type of cancer will take part and a large number of these patients can enter the trial at the same time. The recommended dose from the Phase 1 trial is used for all patients. These trials may take place in a few cancer centres and perhaps in 1 to 2 different countries. If the new treatment or intervention shows effectiveness, it will proceed to Phase 3 testing.